Literature DB >> 17888574

Prevalence of chronic pain with neuropathic characteristics in the general population.

Didier Bouhassira1, Michel Lantéri-Minet, Nadine Attal, Bernard Laurent, Chantal Touboul.   

Abstract

We conducted a large nationwide postal survey to estimate the prevalence of chronic pain with or without neuropathic characteristics in the French general population. A questionnaire aimed at identifying chronic pain (defined as daily pain for at least 3 months), evaluating its intensity, duration and body locations, was sent to a representative sample of 30,155 subjects. The DN4 questionnaire was used to identify neuropathic characteristics. Of the questionnaires, 24,497 (81.2%) were returned and 23,712 (96.8%) could be assessed. Seven thousand five hundred and twenty-two respondents reported chronic pain (prevalence=31.7%; [95%CI: 31.1-32.3]) and 4709 said the pain intensity was moderate to severe (prevalence=19.9%; [95%CI: 19.5-20.4]). Neuropathic characteristics were reported by 1631 respondents with chronic pain (prevalence=6.9%; [95%CI: 6.6-7.2]), which was moderate to severe in 1209 (prevalence=5.1% [95%CI: 4.8-5.4]). A higher prevalence of chronic pain with neuropathic characteristics was associated with middle age (50-64 years), manual professions and those living in rural areas. It was more frequently located in the lower limbs and its intensity and duration were higher in comparison with chronic pain without neuropathic characteristics. This large national population-based study indicates that a significant proportion of chronic pain patients report neuropathic characteristics. We identified distinctive socio-demographic profile and clinical features indicating that chronic pain with neuropathic characteristics is a specific health problem.

Entities:  

Mesh:

Year:  2007        PMID: 17888574     DOI: 10.1016/j.pain.2007.08.013

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  404 in total

Review 1.  Epidemiology of neuropathic pain and its impact on quality of life.

Authors:  Blair H Smith; Nicola Torrance
Journal:  Curr Pain Headache Rep       Date:  2012-06

Review 2.  Targeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain.

Authors:  S Vink; P F Alewood
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 3.  Combination pharmacotherapy for the treatment of neuropathic pain in adults.

Authors:  Luis Enrique Chaparro; Philip J Wiffen; R Andrew Moore; Ian Gilron
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

4.  Acute pain after total hip arthroplasty does not predict the development of chronic postsurgical pain 6 months later.

Authors:  Hance Clarke; Joseph Kay; Nicholas Mitsakakis; Joel Katz
Journal:  J Anesth       Date:  2010-05-19       Impact factor: 2.078

Review 5.  Laboratory tools for assessing neuropathic pain.

Authors:  Giulia Di Stefano; Silvia La Cesa; Antonella Biasiotta; Caterina Leone; Alessia Pepe; Giorgio Cruccu; Andrea Truini
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

Review 6.  Methadone for neuropathic pain in adults.

Authors:  Ewan D McNicol; McKenzie C Ferguson; Roman Schumann
Journal:  Cochrane Database Syst Rev       Date:  2017-05-17

Review 7.  Gabapentin for chronic neuropathic pain and fibromyalgia in adults.

Authors:  R Andrew Moore; Philip J Wiffen; Sheena Derry; Thomas Toelle; Andrew S C Rice
Journal:  Cochrane Database Syst Rev       Date:  2014-04-27

Review 8.  Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain.

Authors:  N Percie du Sert; A S C Rice
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

9.  Neuropathic Pain after Shoulder Arthroplasty: Prevalence, Impact on Physical and Mental Function, and Demographic Determinants.

Authors:  Helen Razmjou; Linda J Woodhouse; Richard Holtby
Journal:  Physiother Can       Date:  2018       Impact factor: 1.037

10.  The therapeutic management of chronic pain in ambulatory care patients aged 65 and over in France: the S.AGES Cohort. Baseline data.

Authors:  P Bertin; L Becquemont; E Corruble; G Derumeaux; B Falissard; O Hanon; M Pinget; F Forette
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.